2008
DOI: 10.1152/ajplung.00325.2007
|View full text |Cite
|
Sign up to set email alerts
|

TIMAP is a positive regulator of pulmonary endothelial barrier function

Abstract: inhibited membrane-associated protein, TIMAP, is expressed at high levels in endothelial cells (EC). It is regarded as a member of the MYPT (myosin phosphatase target subunit) family of protein phosphatase 1 (PP1) regulatory subunits; however, its function in EC is not clear. In our pull-down experiments, recombinant TIMAP binds preferentially the ␤-isoform of the catalytic subunit of PP1 (PP1c␤) from pulmonary artery EC. As PP1c␤, but not PP1c␣, binds with MYPT1 into functional complex, these results suggest … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
60
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 36 publications
(66 citation statements)
references
References 30 publications
(50 reference statements)
3
60
0
Order By: Relevance
“…In 2ME-challenged cells, the intracellular localization of ERM significantly differed from the localization of phospho-ERM, suggesting that only a minor fraction of ERM is phosphorylated. Our data were consistent with previous reports (17,18) showing that phospho-ERM were mostly localized to the peripheral area in endothelial cells undergoing contraction and a loss of monolayer integrity. Of interest, the colocalization of phospho-ERM with F-actin branching points was also described in endothelial cells (42).…”
Section: Discussionsupporting
confidence: 94%
See 2 more Smart Citations
“…In 2ME-challenged cells, the intracellular localization of ERM significantly differed from the localization of phospho-ERM, suggesting that only a minor fraction of ERM is phosphorylated. Our data were consistent with previous reports (17,18) showing that phospho-ERM were mostly localized to the peripheral area in endothelial cells undergoing contraction and a loss of monolayer integrity. Of interest, the colocalization of phospho-ERM with F-actin branching points was also described in endothelial cells (42).…”
Section: Discussionsupporting
confidence: 94%
“…Previously we reported that 2ME causes barrier dysfunction in HPAEC monolayers, and that this process is dependent on the disruption of MTs and the activation of Rho kinase (ROCK) and p38 cascades (16). With the realization that barrier-disruptive signaling events may not be limited to the activation of ROCK and p38, we studied the involvement of protein kinase C (PKC) in response to 2ME.Ezrin/radixin/moesin (ERM) proteins are well-known PKC substrates, emerging as potential candidates in the regulation of barrier permeability (17)(18)(19). Believed to serve as cross-linkers between the actin cytoskeleton and plasma membrane, ERM were also shown to be engaged in cell motility and adhesion.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The LAMR1 is upregulated during EC proliferation and angiogenesis (35,50) and is required for capillary formation in vitro and angiogenesis in vivo (18,31). TIMAP also regulates moesin phosphorylation in EC (11) and can dephosphorylate MLC2 in vitro (48), but its actual mechanism of action in EC is poorly understood.…”
mentioning
confidence: 99%
“…If the physiological PP1cβ activity contributes to the normal maintenance of some cellular functions such as endothelial cell barrier protection, cytoskeleton structure support [9,10,11] and DNA repair [12], its overexpression has been observed in certain cancers, like metastatic melanoma [13], malignant pancreatic tumors [14,15], and breast cancers [16,17]. Additionally, we have recently shown that hypoxia, a major regulator of angiogenesis [18], upregulates the mRNA of protein phosphatase type 1 beta (PP1cβ) in cyanotic children with tetralogy of Fallot (TOF) [19].…”
Section: Introductionmentioning
confidence: 99%